PRCN-226

N/A

Report date: 2025/01/26 16:46:37

Base Information

Drug NamePRCN-226
Drug Alias Nameadeno-associated vector gene therapy (Neuralgene)PRCN-226
ClassificationBiologics
Mechanisms of ActionDopamine receptors agonists
TargetsDopamine receptors
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNeuralgene
China Registration ClassN/A

Develop Information

Active CompaniesNeuralgene
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A